Avapritinib
NAVIGATOR
Blueprint Medicines · Phase 1 · Completed · Enrollment 250
| Arm | Reported safety |
|---|---|
| Avapritinib 300 or 400 mg, PDGFRA exon 18 | n/r |
| Avapritinib, PDGFRA D842V subgroup | n/r |
| Avapritinib, all GIST safety population | intracranial hemorrhage: 1.1%, label pooled GIST |
A count stays a count. This page does not turn a count into a percent.